)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Corbus Pharmaceuticals
Corbus Pharmaceuticals (CRBP) investor relations material
Corbus Pharmaceuticals Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary11 Mar, 2026
Company overview and business model
Clinical-stage company developing therapies in oncology and obesity, focusing on innovative approaches to well-understood biological pathways.
Pipeline includes CRB-701, an antibody drug conjugate targeting Nectin-4 in cancer, and CRB-913, a CB1 receptor inverse agonist for obesity.
CRB-701 is in Phase 1/2 trials in the US and Europe, with fast track FDA designations for certain cancers; CRB-913 completed Phase 1a and is in Phase 1b for obesity.
Former oncology program CRB-601 has been deprioritized after Phase 1 dose escalation.
Financial performance and metrics
Audited consolidated financial statements for years ended December 31, 2025 and 2024, with an unqualified opinion from EisnerAmper LLP.
As of March 6, 2026, 17,736,464 shares of common stock were issued and outstanding.
Use of proceeds and capital allocation
Net proceeds will be used for general corporate purposes, including research, development, clinical trials, acquisitions, working capital, debt reduction, and capital expenditures.
Pending use, proceeds may be invested in short-term, interest-bearing instruments or investment-grade securities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Corbus Pharmaceuticals
- CRB-701 and CRB-913 show strong clinical promise, with pivotal data expected in 2026.CRBP
Corporate presentation9 Mar 2026 - Strong clinical progress and financing position support continued development into 2028.CRBPQ4 20259 Mar 2026
- Transformative clinical data for oncology and obesity assets expected in 2024.CRBPOppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026
- Pivotal 2026 data expected for lead oncology and obesity programs, with strong early results.CRBPCorporate presentation25 Feb 2026
- Advancing oncology and obesity programs with strong cash position and key data expected in 2024-2025.CRBPGoldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026
- CB-1 and Nectin-4 ADC programs advance with promising safety, efficacy, and key data expected soon.CRBP2024 Cantor Fitzgerald Global Healthcare Conference20 Jan 2026
- CRB-701 and CRB-913 advance with strong data, regulatory clarity, and funding into 2028.CRBP44th Annual J.P. Morgan Healthcare Conference15 Jan 2026
- CRB-701 and CRB-913 advance with promising efficacy, safety, and major 2026 milestones ahead.CRBPCorporate presentation15 Jan 2026
- Key data for Nectin-4 ADC and CRB-913 obesity program expected in 2025–2026.CRBPGuggenheim Inaugural Global Healthcare Innovation Conference14 Jan 2026
Next Corbus Pharmaceuticals earnings date
Q1 20268 May, 2026
Corbus Pharmaceuticals
Next Corbus Pharmaceuticals earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage